| Literature DB >> 26087331 |
Karley K Mahalak1, Helen M Chamberlin2.
Abstract
Entities:
Mesh:
Substances:
Year: 2015 PMID: 26087331 PMCID: PMC4473725 DOI: 10.1371/journal.pgen.1005254
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Fig 1Proposed model for genetic evolution in P. pacificus dauer formation.
A) Conserved features of the dauer formation pathway. In endocrine cells, cholesterol is a substrate for the biosynthesis of dafachronic acid (DA), a DAF-12 ligand that suppresses the ability of DAF-12 to promote dauer formation. B) Model for the RS5134/Ohio strain with one copy of dauerless (dau-1.1). dau-1.1 is expressed in the CAN neuron cells and acts (genetically) to inhibit DAF-12 function and thereby inhibit dauer formation. C) The RS2333/California strain has two copies of dauerless (dau-1.1 and dau-1.2), and a corresponding double effect of inhibition of dauer formation.